Recent RARE Stock Price | RARE Stock Predictions | |
$43.38 | +109.04% |
$90.68 |
Recent RARE Analyst Ratings Breakdown, Making RARE Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 18 | 18 | 18 | 17 |
Buy ratings: | 0 | 0 | 0 | 0 |
Hold ratings: | 2 | 2 | 2 | 2 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 1.2 | 1.2 | 1.2 | 1.21 |
For the RARE stock predictions from the analysts covering Ultragenyx Pharmaceutical Inc, we have collected all of the individual RARE stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 19 different analysts covering RARE (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since RARE stock predictions may vary widely, another useful metric to consider is the median RARE stock prediction, which represents the price at which half of the analysts
made RARE stock predictions that were higher and half made RARE stock predictions that were lower. This makes for a different take on the RARE stock predictions out there, as compared to average or mean.
And that median across all the individual RARE stock predictions was: $85.0 as of 2024-04-19.
The very highest of the RARE stock predictions for one year price target was $140.0, while the very lowest of the RARE stock predictions in the analyst group was
$48.0 (with a standard deviation of $29.7). Get the latest Zacks research report on RARE — FREE
Find out: RARE next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
RRGB Stock Predictions
USAC Stock Predictions
IRM Stock Predictions
ERJ Stock Predictions
BLNK Stock Predictions
DVAX Stock Predictions
CG Stock Predictions
FPRX Stock Predictions
APPN Stock Predictions
|
|
Strong Buy (3.80 out of 4) 100th percentile
(ranked higher than approx. 100% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |